查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1448760

全球即时 PCR、数位 PCR 和终点 PCR 市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Real-time PCR, Digital PCR, And End-point PCR Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 292 Pages | 商品交期: 最快1-2个工作天内

价格

全球即时 PCR、数位 PCR 和终点 PCR 市场需求预计将从 2023 年的 81.6 亿美元增至 2032 年的近 128.1 亿美元，2024 年研究期间复合CAGR为 5.14% - 2032.

聚合酶炼式反应 (PCR) 是一种用于扩增和分析 DNA 的分子生物学技术。 PCR 有多种变体，包括即时 PCR、数位 PCR 和终点 PCR，每种都有自己的应用和优点。

市场动态

由于 PCR 技术在 COVID-19 检测中的关键作用，全球对 PCR 技术的需求激增。这次大流行凸显了检测 SARS-CoV-2 病毒遗传物质的重要性。除了传染病诊断之外，PCR 仍然是分子诊断的基石，有助于其扩展。生命科学研究的进步，特别是基因组学和蛋白​​质组学的进步，进一步推动了对该技术的需求。遗传性疾病病例的增加以及对精确和早期诊断的需求推动了基于 PCR 的方法在基因检测中的采用。即时 PCR 和数位 PCR 等技术的不断进步提高了 DNA 扩增的效率和灵敏度，从而促进了市场成长。此外，对即时检测解决方案的需求以及便携式 PCR 技术在快速诊断中的应用也有助于市场的扩张。在製药和生物技术行业，PCR 是药物开发、发现和品质控制不可或缺的一部分，进一步推动了其市场占有率。随着 PCR 不断发展并在不同领域找到应用，其市场预计将持续成长，以适应不断变化的诊断和研究需求。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球即时 PCR、数位 PCR 和终点 PCR 市场的各个细分市场进行了包容性评估。即时 PCR、数位 PCR 和终点 PCR 产业的成长和趋势为本研究提供了整体方法。

市场区隔

即时 PCR、数位 PCR 和终点 PCR 市场报告的这一部分提供了国家和区域层级细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

依技术

  • 定量
  • 数位的
  • 终点

按产品分类

  • 耗材及试剂
  • 仪器
  • 软体与服务

按应用类型

  • 临床（病原体检测、肿瘤学检测、血液筛检、液体活检、基于 Dpcr 的非侵入性产前检测 (Nipt) 等）
  • 研究（干细胞研究、DNA 克隆和定序、重组 DNA 技术、罕见突变检测、基因表现、单细胞分析、微生物组分析、拷贝数变异分析、文库定量 (NGS)、mRNA 和 miRNA 低倍变化的表征、转基因生物检测）
  • 法医

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲即时 PCR、数位 PCR 和终点 PCR 市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。即时 PCR、数位 PCR 和终点 PCR 市场的主要参与者包括 Abbott、Qiagen、Bio-Rad Laboratories Inc.、Agilent Technologies, Inc.、Thermo Fisher Scientific, Inc.、GE Healthcare、bioMerieux、F . Hoffmann-La Roche Ltd 、Fluidigm Corporation。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：即时 PCR、数位 PCR 和终点 PCR - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按技术分類的市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 按应用类型分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球即时 PCR、数位 PCR 和终点 PCR 市场分析：按技术分类

  • 依技术概述
  • 历史和预测数据
  • 依技术分析
  • 定量
  • 数位的
  • 终点

第 6 章：全球即时 PCR、数位 PCR 和终点 PCR 市场分析：副产品

  • 按产品概述
  • 历史和预测数据
  • 按产品分析
  • 耗材及试剂
  • 仪器
  • 软体与服务

第 7 章：全球即时 PCR、数位 PCR 和终点 PCR 市场分析：按应用类型

  • 按应用程式类型概述
  • 历史和预测数据
  • 按应用程式类型分析
  • 临床（病原体检测、肿瘤学检测、血液筛检、液体活检、基于 dPCR 的非侵入性产前检测 (NIPT) 等）
  • 研究（干细胞研究、DNA 克隆和定序、重组 DNA 技术、罕见突变检测、基因表现、单细胞分析、微生物组分析、拷贝数变异分析、文库定量 (NGS)、mRNA 和 miRNA 低倍变化的表征、转基因生物检测）
  • 法医

第 8 章：全球即时 PCR、数位 PCR 和终点 PCR 市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 9 章：即时 PCR、数位 PCR 和终点 PCR 公司的竞争格局

  • 即时PCR、数位PCR和终点PCR市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 10 章：公司简介

  • 公司股份分析
  • 市场集中度
  • Abbott
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Qiagen
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Bio-Rad Laboratories Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Agilent Technologies Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Thermo Fisher Scientific Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • GE Healthcare
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • bioMerieux
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • F. Hoffmann-La Roche Ltd
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Fluidigm Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR112113580

The global demand for Real-time PCR, Digital PCR, And End-point PCR Market is presumed to reach the market size of nearly USD 12.81 BN by 2032 from USD 8.16 BN in 2023 with a CAGR of 5.14% under the study period 2024 - 2032.

Polymerase Chain Reaction (PCR) is a molecular biology technique used to amplify and analyze DNA. There are several variations of PCR, including real-time PCR, digital PCR, and endpoint PCR, each with its own applications and advantages.

MARKET DYNAMICS

The global demand for PCR technology has surged due to its pivotal role in COVID-19 testing. The pandemic has highlighted its importance in detecting the genetic material of the SARS-CoV-2 virus. Beyond infectious disease diagnostics, PCR remains a cornerstone in molecular diagnostics, contributing to its expansion. Advances in life sciences research, particularly in genomics and proteomics, further fuel the demand for this technology. The rising cases of genetic disorders and the need for precise and early diagnosis propel the adoption of PCR-based methods in genetic testing. Continuous technological advancements, including real-time PCR and digital PCR, enhance the efficiency and sensitivity of DNA amplification, reinforcing market growth. Additionally, the demand for point-of-care testing solutions and the application of portable PCR technologies in rapid diagnostics contribute to the market's expansion. In the pharmaceutical and biotechnology industries, PCR is integral for drug development, discovery, and quality control, further driving its market presence. As PCR continues to evolve and find applications across diverse sectors, its market growth is expected to persist, adapting to the changing landscape of diagnostic and research needs.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of real-time pcr, digital pcr, and end-point pcr. The growth and trends of real-time pcr, digital pcr, and end-point pcr industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the real-time pcr, digital pcr, and end-point pcr market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

  • Quantitative
  • Digital
  • End-Point

By Product

  • Consumables & Reagents
  • Instruments
  • Software & Services

By Application Type

  • Clinical (Pathogen Testing, Oncology Testing, Blood Screening, Liquid Biopsy, Dpcr-Based Non-Invasive Prenatal Testing (Nipt), Others)
  • Research (Stem Cell Research, DNA Cloning & Sequencing, Recombinant DNA Technology, Rare Mutation Detection, Gene Expression, Single Cell Analysis, Microbiome Analysis, Copy Number Variation Analysis, Library Quantification (NGS), Characterization of Low-fold Changes in mRNA and miRNA, GMO Detection)
  • Forensic

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Real-time PCR, Digital PCR, And End-point PCR market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Real-time PCR, Digital PCR, And End-point PCR market include Abbott, Qiagen, Bio-Rad Laboratories Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., GE Healthcare, bioMerieux, F. Hoffmann-La Roche Ltd, Fluidigm Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Technology
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Application Type
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR MARKET ANALYSIS BY TECHNOLOGY

  • 5.1 Overview by Technology
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Technology
  • 5.4 Quantitative Historic and Forecast Sales by Regions
  • 5.5 Digital Historic and Forecast Sales by Regions
  • 5.6 End-point Historic and Forecast Sales by Regions

6 . GLOBAL REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Consumables & Reagents Historic and Forecast Sales by Regions
  • 6.5 Instruments Historic and Forecast Sales by Regions
  • 6.6 Software & Services Historic and Forecast Sales by Regions

7 . GLOBAL REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR MARKET ANALYSIS BY APPLICATION TYPE

  • 7.1 Overview by Application Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application Type
  • 7.4 Clinical (Pathogen Testing, Oncology Testing, Blood Screening, Liquid Biopsy, dPCR-based Non-Invasive Prenatal Testing (NIPT), Others) Historic and Forecast Sales by Regions
  • 7.5 Research (Stem Cell Research, DNA Cloning & Sequencing, Recombinant DNA Technology, Rare Mutation Detection, Gene Expression, Single Cell Analysis, Microbiome Analysis, Copy Number Variation Analysis, Library Quantification (NGS), Characterization of Low-fold Changes in mRNA and miRNA, GMO Detection) Historic and Forecast Sales by Regions
  • 7.6 Forensic Historic and Forecast Sales by Regions

8 . GLOBAL REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR COMPANIES

  • 9.1. Real-Time Pcr, Digital Pcr, And End-Point Pcr Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Abbott
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Qiagen
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Bio-Rad Laboratories Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Agilent Technologies Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Thermo Fisher Scientific Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. GE Healthcare
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. bioMerieux
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. F. Hoffmann-La Roche Ltd
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Fluidigm Corporation
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Technology (USD MN)
  • Quantitative Market Sales by Geography (USD MN)
  • Digital Market Sales by Geography (USD MN)
  • End-point Market Sales by Geography (USD MN)
  • Analysis Market by Product (USD MN)
  • Consumables & Reagents Market Sales by Geography (USD MN)
  • Instruments Market Sales by Geography (USD MN)
  • Software & Services Market Sales by Geography (USD MN)
  • Analysis by Application Type (USD MN)
  • Clinical (Pathogen Testing, Oncology Testing, Blood Screening, Liquid Biopsy, dPCR-based Non-Invasive Prenatal Testing (NIPT), Others) Market Sales by Geography (USD MN)
  • Research (Stem Cell Research, DNA Cloning & Sequencing, Recombinant DNA Technology, Rare Mutation Detection, Gene Expression, Single Cell Analysis, Microbiome Analysis, Copy Number Variation Analysis, Library Quantification (NGS), Characterization of Low-fold Changes in mRNA and miRNA, GMO Detection) Market Sales by Geography (USD MN)
  • Forensic Market Sales by Geography (USD MN)
  • Global Real-Time Pcr, Digital Pcr, And End-Point Pcr Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Real-Time Pcr, Digital Pcr, And End-Point Pcr Report
  • Market Research Process
  • Market Research Methodology
  • Global Real-Time Pcr, Digital Pcr, And End-Point Pcr Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Application Type
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Technology (USD MN)
  • Quantitative Market Sales by Geography (USD MN)
  • Digital Market Sales by Geography (USD MN)
  • End-point Market Sales by Geography (USD MN)
  • Global Market Analysis by Product (USD MN)
  • Consumables & Reagents Market Sales by Geography (USD MN)
  • Instruments Market Sales by Geography (USD MN)
  • Software & Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Application Type (USD MN)
  • Clinical (Pathogen Testing, Oncology Testing, Blood Screening, Liquid Biopsy, dPCR-based Non-Invasive Prenatal Testing (NIPT), Others) Market Sales by Geography (USD MN)
  • Research (Stem Cell Research, DNA Cloning & Sequencing, Recombinant DNA Technology, Rare Mutation Detection, Gene Expression, Single Cell Analysis, Microbiome Analysis, Copy Number Variation Analysis, Library Quantification (NGS), Characterization of Low-fold Changes in mRNA and miRNA, GMO Detection) Market Sales by Geography (USD MN)
  • Forensic Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.